 NEWTON, Mass., Dec. 11, 2020 PRNewswire -- Karyopharm Therapeutics Inc. Nasdaq:KPTI, a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the National Comprehensive Cancer Network NCCN added three different XPOVIO selinexor... 